Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of HWH486 in adults with chronic spontaneous urticaria
ChiCTR2500097083Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2025
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HWH486 in chronic idiopathic urticaria (CIU) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Change in Urticaria Activity Score over 7 days. Started Feb 2025; status: recruiting.
02
Drugs
HWH486
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on ChiCTR2500097083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097083.